335757 <common-name>2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenoxy]propyl]amino]ethoxy]benzamide;methanesulfonic acid</common-name> <description>2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenoxy]propyl]amino]ethoxy]benzamide;methanesulfonic acid is a chemical compound with the formula C24H29F3N4O8S. With an average molecular weight of 590.60 g/mol, 2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenoxy]propyl]amino]ethoxy]benzamide;methanesulfonic acid is a heavy molecule.</description> <cas>105737-62-0</cas> <pubchem-id>10008573</pubchem-id> <chemical-formula>C24H29F3N4O8S</chemical-formula> <weight>590.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T17:59:50Z</created-at> <updated-at type="dateTime">2026-08-30T17:59:50Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CN1C=C(N=C1C2=CC=C(C=C2)OCC(CNCCOC3=CC(=C(C=C3)O)C(=O)N)O)C(F)(F)F.CS(=O)(=O)O</moldb-smiles> <moldb-formula>C24H29F3N4O8S</moldb-formula> <moldb-inchi>InChI=1S/C23H25F3N4O5.CH4O3S/c1-30-12-20(23(24,25)26)29-22(30)14-2-4-16(5-3-14)35-13-15(31)11-28-8-9-34-17-6-7-19(32)18(10-17)21(27)33;1-5(2,3)4/h2-7,10,12,15,28,31-32H,8-9,11,13H2,1H3,(H2,27,33);1H3,(H,2,3,4)</moldb-inchi> <moldb-inchikey>VFPOVCXWKBYDNF-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">590.1658196</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp nil="true"/> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM331650</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenoxy]propyl]amino]ethoxy]benzamide;methanesulfonic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Imidazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0286223</sync-id> <structure-inchikey>VFPOVCXWKBYDNF-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>400400000000000000008000020222000008000000000000000000001000000000000000000004012040000200000020000000000002000000008000002000000000000000000200000080020000000000202010000009000002000000000000000000000140000000000000001000008000004011000000000000000048000000200000400000000000000000020040808010000000001000000000000000000000000000000000000000000800000040000020040c0000584000040000000000000000000000002100000000000000000000001000002000000200000000000000000000010001000040000000000400800000000000000100000000000200</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAoAAAAKQAAAIABBgBgAAAAAQMHQCgAAAAD AwZAaAAAAAMDAQZAKAAAAAMEB0AoAAAAAwMGQCgAAAADBAZAKAAAAAMEBkBo AAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEIACgA AAADAgYAYAAAAAICBgBgAAAAAwEGAGAAAAACAgcAYAAAAAIBBgBgAAAAAgIG AGAAAAACAggAKAAAAAMCBkAoAAAAAwQGQGgAAAADAwEGQCgAAAADBAZAKAAA AAMEBkBoAAAAAwMBBkBoAAAAAwMBCABoAAAAAwEBBgAoAAAAAwQIACgAAAAD AgcAaAAAAAMBAggAYAAAAAEBBgAgAAAABAkAIAAAAAEJACAAAAABCQAgAAAA AQYAYAAAAAEDEAAgAAAABggAKAAAAAMCCAAoAAAAAwIIAGAAAAABAQsAAQAB AmgMAgNoDAMEaAwEBWgMBQYgBgdoDAcIaAwICWgMCQpoDAoLaAwJDCAMDQAN DgAODwAPEAAQEQAREgASEwATFCAUFWgMFRZoDBYXaAwXGGgMGBloDBcaIBYb IBscKAIbHSAOHgADHwAfIAAfIQAfIgAjJAAkJQgCJCYIAiQnAAUBaAwLBmgM GRRoDEIDAAAABQECAwQFBgcICQoLBgYVFhcYGRQXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:37:24Z</structure-indexed-at> </compound>